No infringement here, Fed Circuit says in ruling for Boston Sci
· mari serebrov
AI Briefing
- • US Court of Appeals for the Federal Circuit reverses jury verdict on Boston Sci patent infringement.
- • Boston Scientific Corp. wins case on drug-eluting coronary stent systems patent infringement.
- • Ruling finds no infringement on University of Texas System patent.
Context
The U.S. Court of Appeals for the Federal Circuit reversed a jury verdict on July 27. The verdict had found Boston Scientific Corp's drug-eluting coronary stent systems infringed a University of Texas System patent. Boston Scientific Corp came out as the winner.
The ruling matters as it clears Boston Scientific Corp of infringement claims. The Federal Circuit's decision reverses the jury verdict that initially found the company's stent systems to be in violation of the University of Texas System patent.
Advertisement